Pomerantz Law Firm Announces the Filing of a Class Action

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2022
49
Pomerantz Law Firm Announces the Filing of a Class Action against Activision Blizzard, Inc. and Certain Officers – ATVI

NEW YORK, Jan. 18, 2019 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Activision Blizzard, Inc. (“Activision Blizzard” or the “Company”) (NASDAQ:  ATVI) and certain of its officers.  The class action, filed in United States District Court, Central District of California, and docketed under 19-cv-00423, is on behalf of a class consisting of all persons other than Defendants who purchased or otherwise acquired Activision securities between August 2, 2018 and January 10, 2019, both dates inclusive (the “Class Period”), seeking to recover damages caused by Defendants’ violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and Rule 10b-5 promulgated thereunder, against the Company and certain of its top officials.

If you are a shareholder who purchased Activision Blizzard securities between August 2, 2018, and January 10, 2019, both dates inclusive, you have until March 19, 2019, to ask the Court to appoint you as Lead Plaintiff for the class.  A copy of the Complaint can be obtained at www.pomerantzlaw.com .   To discuss this action, contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and number of shares purchased. 

[Click here to join this class action]

Activision Blizzard develops and distributes content and services on video game consoles, personal computers (PC), and mobile devices. 

On April 29, 2010, the Company announced its entry, through its wholly-owned subsidiary Activision Publishing, Inc., into an agreement with Bungie, Inc. (“Bungie”), the developer of blockbuster game franchises including Halo , Myth, and Marathon .  The agreement with Bungie gave Activision Blizzard exclusive rights to publish and distribute video games developed by Bungie for the next ten years.

The partnership between Activision Blizzard and Bungie yielded the commercially successful Destiny franchise, a series of science fiction-themed video games.  In September 2014, Activision Blizzard released Destiny , the first installment in the franchise, developed by Bungie.  Activision Blizzard announced that the Company sold $500 million of Destiny into retail stores and first parties worldwide on the first day of its release, making the game the largest video game franchise launch in history at that time.  Over the following two years, Bungie developed and Activision Blizzard released four expansions for Destiny .  In September 2017, Activision Blizzard released a full sequel, Destiny 2 .  On September 15, 2017, Activision Blizzard announced that Destiny 2 had “surpassed the original’s records for engagement and digital sales in launch week.”  To date, Bungie has developed and Activision Blizzard has released three expansions for Destiny 2 .

The complaint alleges that throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies.  Specifically, Defendants made false and/or misleading statements and/or failed to disclose that:  (i) the termination of Activision Blizzard and Bungie’s partnership, giving Bungie full publishing rights and responsibilities for the Destiny franchise, was imminent; (ii) the termination of the two companies’ relationship would foreseeably have a significant negative impact on Activision Blizzard’s revenues; and (iii) as a result, Activision Blizzard’s public statements were materially false and misleading at all relevant times.

On January 10, 2019, Activision Blizzard and Bungie announced the end of their business relationship.  That same day, in an Securities and Exchange Commission filing, Activision Blizzard stated that Bungie “would assume full publishing rights and responsibilities for the Destiny franchise.  Going forward, Bungie will own and develop the franchise.”

Following these announcements, the Company’s stock price fell $4.81 per share, or 9.37%, to close at $46.54 on January 11, 2019.

The Pomerantz Firm, with offices in New York, Chicago, Florida, and Los Angeles, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com

CONTACT: Robert S. Willoughby Pomerantz LLP rswilloughby@pomlaw.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Capacity LLC: Finalist in 2026 BeautyMatter Awards

Updated Category News Views 111

A Nod to Logistics and Beauty When beauty meets logistics, you end up with something like Capacity LLC making headlines in the 2026 BeautyMatter Awards. Now, I ain't one to usually get excited about anything involving freight and boxes, but this isn't just any nod in the 'Best Logistics Solution' category; it speaks volumes about where the beauty business is heading. Why...

Continue Reading
Piramal Pharma FY27 Q2 Results: Robust Growth & Optimism

Updated Category News Views 38

A Solid Performance from Piramal Pharma The numbers are in, and it's looking pretty good for Piramal Pharma Limited this time around. Their second quarter of fiscal year 2027 has seen some fireworks, and I'm not talking about some half-baked confetti deal. We're talking genuine growth and solid metrics here. Revenue and Profit Surge The headline? Revenue jumped a whopping...

Continue Reading
Kimberly-Clark Extends Kenvue Notes Exchange Deadline

Updated Category News Views 72

Deadline Extended for Kenvue's Noteholders In the wild world of corporate finance, the only thing more unpredictable than the weather is a boardroom decision. Kimberly-Clark (NASDAQ: KMB) just threw one such curveball by extending the deadline on their exchange offers for Kenvue Notes to November 2, 2026. Seems like 5 p.m. New York time is the new witching hour for this...

Continue Reading
DICK'S Sporting Goods Faces Investor Lawsuit Deadline Looms

Updated Category News Views 23

A Rough Tumble for DICK'S Sporting Goods Let's cut to the chase: DICK'S Sporting Goods, Inc. (NYSE:DKS) just took a nosedive. We're talking a hard 30.68% fall on the stock, plummeting to $124.31 a share as of August 25, 2026. Now, if you were caught up in this whirlwind as an investor, you'd be forgiven for having a few choice words for the powers that be over at DICK'S....

Continue Reading
Political Jitters Push US Investors to Golden Visas

Updated Category News Views 118

Judging by the latest buzz from La Vida's 2026 survey, the golden ticket for many US investors isn't a hot stock but something far more unexpected: the coveted 'Golden Visa.' Out of over 5,000 wealthy individuals invited to participate, 94.3% are mulling over a second residency or citizenship, and the big trigger? Political concerns. It's a clear sign that plenty of...

Continue Reading
GeneDx Faces Scrutiny: Are Fiduciary Duties at Risk?

Updated Category News Views 71

What's Brewing at GeneDx? Looks like GeneDx Holdings Corp. is in some hot water—at least that's what Halper Sadeh LLC seems to think. Not your regular Tuesday at the exchange, folks. This legal eagle outfit is poking around GeneDx's henhouse, signaling possible breaches of fiduciary duties by their officers and directors. It's like catching a whiff of something fishy...

Continue Reading
BNY's Conference Spotlight: Strategic Moves Ahead?

Updated Category News Views 119

BNY's CFO to Unpack Strategies at BMO Financials Conference They say you can tell a lot about a company by the folks steering the ship. And let me tell you, folks, Dermot McDonogh from BNY is setting sail over to Boca Raton to spill some beans. November 9 marks the date when BNY’s Chief Financial Officer will stand behind the mic at the BMO Financials Conference at 8:45...

Continue Reading
CELSET Unveils SOLTOX: Expanding in Global Markets

Updated Category News Views 9

New Contender in the Global Botulinum Toxin Arena Launching a fresh player onto the international stage, CELSET INC. from Seoul throws down with SOLTOX, their own botulinum toxin Type A brand. This ain't your run-of-the-mill roll-out; it's another notch for Korean biotech trying to snag a piece of global market action. A Look at SOLTOX's Technical Makeup We’re talking...

Continue Reading
Jennifer Sharp Bolsters Signature Wealth's Greenville Team

Updated Category News Views 88

New Beginnings with Signature Wealth There's a fresh breeze blowing through Signature Wealth's Greenville office, and its name is Jennifer Sharp. Now, if you're meandering through financial landscapes, Sharp is the guide you didn’t know you needed—until now. With nearly 20 years under her belt, she brings a wealth of experience coupled with a knack for handling life's...

Continue Reading
Photocure's Q3 2026: Revenue Plateau and CFO Shakeup

Updated Category News Views 7

The Bladder Cancer Scene: Steady as She Goes Sometimes, you look at numbers and find tranquility, like staring into still waters. That's the scene over at Photocure ASA with their latest Q3 results. Clocking in with revenues of NOK 134.2 million from their Hexvix®/Cysview® products, they're barely flinching from last year's NOK 134.1 million. Is it a victory or a...

Continue Reading

Top 5 Most Recently Viewed Articles

Nvidia's Global Competition at Risk Amid U.S. AI Legislation

Updated Category News Views 393

Nvidia Raises Concerns Over Legislative Changes NVIDIA Corp. (NASDAQ: NVDA) has expressed significant concerns regarding proposed legislation in Congress, which aims to limit its ability to sell chips globally. This comes in the wake of a recent export agreement between President Trump and NVIDIA that allows chip sales to China. The company argues that the new legislative...

Continue Reading
Olin Corporation Insights on Adjusted EBITDA for 2025

Updated Category News Views 209

Olin Corporation Offers Updated Outlook for Fourth Quarter Olin Corporation (NYSE: OLN) has provided insights regarding its performance for the fourth quarter of 2025, indicating a significant deviation from its previous expectations. The latest forecast suggests an adjusted EBITDA of nearly $67 million, a notable decrease from the earlier anticipated range of $110 to...

Continue Reading
Innovature BPO Welcomes Thoai Nguyen as COO to Enhance Operations

Updated Category News Views 134

Raising Standards in Business Process Outsourcing Innovature BPO is making headlines with the recent appointment of Thoai Nguyen as Chief Operating Officer. This strategic decision reflects the company's ambition to enhance its operational effectiveness and continue providing exceptional service in outsourcing. With a commitment to integrating AI-driven solutions,...

Continue Reading
TCL and F-Secure: Innovating Secure Connectivity Together

Updated Category News Views 224

TCL and F-Secure Forge a Strategic Partnership TCL, renowned for its innovations in display technology, has recently proclaimed a robust alliance with F-Secure, a leader in cybersecurity. This strategic collaboration was unveiled during Network X 2025 and aims to bolster the security features in TCL's products across Fixed Broadband (FBB), Fixed Wireless Access (FWA), and...

Continue Reading
Innovative Aromatherapy Fan Enhances Comfort and Relaxation

Updated Category News Views 154

Introduction to the Aromatherapy Accessory In today's fast-paced world, finding ways to unwind and relax is essential for maintaining overall well-being. What if you could enjoy the calming effects of aromatherapy while staying cool? An innovative inventor from Crown Point, Indiana, set out to create a solution that combines the benefits of aromatherapy with the...

Continue Reading